| BSE: 500087 | Sector: Health care |
| NSE: CIPLA | ISIN Code: INE059A01026 |
| BSE 00:00 | 07 Dec | 515.10 |
-2.10 (-0.41%) |
OPEN
520.00 |
HIGH
530.40 |
LOW
512.65 |
| NSE 00:00 | 07 Dec | 513.60 |
-1.70 (-0.33%) |
OPEN
520.00 |
HIGH
530.65 |
LOW
512.00 |
| OPEN | 520.00 |
| PREVIOUS CLOSE | 517.20 |
| VOLUME | 177071 |
| 52-Week high | 678.00 |
| 52-Week low | 508.10 |
| P/E | 24.97 |
| Mkt Cap.(Rs cr) | 41,499 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Cipla Ltd is one of the leading pharmaceutical companies in India. The company focuses on development of new formulations and has a wide range of pharmaceutical products. The product portfolio includes over 1500 products across wide range of therapeutic categories.Cipla Ltd was incorporated in the year 1935 with the name Chemical Industrial & Pharmaceutical Laboratories Ltd. Khwaja Abdul Hamied th...> More
| Parameter | Values | ||
| Market Cap | ( cr) |
41,499 | |
| EPS - TTM | () |
[*S] | 20.63 |
| P/E Ratio | (X) | [*S] | 24.97 |
| Face Value | () |
2 | |
| Latest Dividend | (%) | 150.00 | |
| Latest Dividend Date | 13 Aug 2018 | ||
| Dividend Yield | (%) | 0.58 | |
| Book Value / Share | () |
[*S] | 183.39 |
| P/B Ratio | () |
[*S] | 2.81 |
Sector Watch: Nifty Pharma index slips up to 3% dragged by Sun Pharma
Drug firms rationalise portfolio, expect pricing pressure to ease in US
Cipla to acquire US specialty drugmaker Avenue Therapeutics for Rs 15.6 bn
Cipla shares continue to fall post Q2 results; plunge nearly 6%
Cipla hits five-month low on weak outlook; down 12% in two days
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Cipla Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Cipla Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Particulars ( cr) |
Sep 2018 | Sep 2017 | % Chg |
| Net Sales | 4011.9 | 4082.41 | -1.73 |
| Other Income | 132.57 | 113.33 | 16.98 |
| Total Income | 4144.47 | 4195.74 | -1.22 |
| Total Expenses | 3309.68 | 3278.02 | 0.97 |
| Operating Profit | 834.79 | 917.72 | -9.04 |
| Net Profit | 366.13 | 436.06 | -16.04 |
| Equity Capital | 161.05 | 160.94 | - |
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Sun Pharma.Inds. | 411.30 | -2.09 | 98683.21 |
| Dr Reddy's Labs | 2683.70 | 1.57 | 44560.15 |
| Aurobindo Pharma | 751.65 | 0.01 | 44039.17 |
| Cipla | 515.10 | -0.41 | 41499.03 |
| Divi's Lab. | 1491.50 | 2.09 | 39591.87 |
| Piramal Enterp. | 2085.95 | -0.64 | 38245.89 |
| Lupin | 839.90 | -0.59 | 37984.48 |
|
|
|
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -4.59% | -5.04% | -1.44% | -1.68% |
| 1 Month | -3.42% | -3.70% | 1.24% | 0.90% |
| 3 Month | -22.41% | -22.74% | -7.08% | -7.73% |
| 6 Month | -4.66% | -5.01% | 0.59% | -0.69% |
| 1 Year | -13.06% | -13.46% | 8.27% | 5.18% |
| 3 Year | -20.14% | -20.40% | 39.73% | 37.71% |
| Today's Low/High | 512.65 |
|
530.40 |
| Week Low/High | 512.25 |
|
549.00 |
| Month Low/High | 512.15 |
|
549.00 |
| YEAR Low/High | 508.10 |
|
678.00 |
| All TIME Low/High | 0.61 |
|
752.00 |
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other
Details
